Daisuke Ikeda

17PUBLICATIONS
22CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 22, 2026
Soluble BCMA Defines Spatial Phenotypes and Prognosis in Newly Diagnosed Multiple Myeloma.

|Dec 26, 2025
Efficacy and relapse profiles of Pola-R-CHP versus R-CHOP in previously untreated diffuse large B-cell lymphoma: A multicentre real-world study.

Toshiki Terao, Isao Yoshida, Hiroki Kobayashi

|Oct 08, 2025
Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemia.

Mitsuaki Oura, Daisuke Ikeda, Shuichi Aikawa

|Sep 04, 2025
Late-Onset Invasive Aspergillosis With Pituitary Involvement and Dysfunction Following CD19 Chimeric Antigen Receptor T-Cell Therapy.

Daisuke Ikeda, Tomohiro Nawada, Takumi Kondo

|Oct 23, 2024
Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma.

Daisuke Ikeda, Shuichi Aikawa, Chiho Misono

|Dec 27, 2023
Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma.

Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura

Pageof 3

Frequent Collaborators

11 joint publications

Kosei Matsue

9 joint publications

Kentaro Narita

6 joint publications

Mitsuaki Oura

4 joint publications

Toshiki Terao